tiprankstipranks
Rapport Therapeutics, Inc. (RAPP)
:RAPP
US Market

Rapport Therapeutics, Inc. (RAPP) Technical Analysis

Compare
26 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
6Neutral
6Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Neutral
5Bullish
0Neutral
5Bearish
Rapport Therapeutics, Inc.’s (RAPP) Moving Averages Convergence Divergence (MACD) indicator is -0.94, suggesting Rapport Therapeutics, Inc. is a Sell.
Rapport Therapeutics, Inc.’s (RAPP) 20-Day exponential moving average is 10.50, while Rapport Therapeutics, Inc.’s (RAPP) share price is $9.72, making it a Sell.
Rapport Therapeutics, Inc.’s (RAPP) 50-Day exponential moving average is 12.80, while Rapport Therapeutics, Inc.’s (RAPP) share price is $9.72, making it a Sell.

Rapport Therapeutics, Inc. (RAPP) Pivot Points

Mar 25, 2025, 10:54 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
7.98
8.55
9.13
9.70
10.28
10.85
11.43
Fibonacci
8.55
8.99
9.26
9.70
10.14
10.41
10.85
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Rapport Therapeutics, Inc. (RAPP) Moving Averages

Mar 25, 2025, 10:54 PM
Period
Simple
Exponential
MA5
9.95Buy
10.00Buy
MA10
9.94Buy
9.97Buy
MA20
9.78Buy
10.50Sell
MA50
12.78Sell
12.80Sell
MA100
17.08Sell
15.49Sell
MA200
Rapport Therapeutics, Inc.’s (RAPP) 10-Day exponential moving average is 9.97, while Rapport Therapeutics, Inc.’s (RAPP) share price is $9.72, making it a Buy.
Rapport Therapeutics, Inc.’s (RAPP) 100-Day exponential moving average is 15.49, while Rapport Therapeutics, Inc.’s (RAPP) share price is $9.72, making it a Sell.
Rapport Therapeutics, Inc.’s (RAPP) stock price is $9.72 and Rapport Therapeutics, Inc.’s (RAPP) 50-day simple moving average is 12.78, creating a Sell signal.
Rapport Therapeutics, Inc.’s (RAPP) stock price is $9.72 and Rapport Therapeutics, Inc.’s (RAPP) 100-day simple moving average is 17.08, creating a Sell signal.

Rapport Therapeutics, Inc. (RAPP) Technical Indicators

Mar 25, 2025, 10:54 PM
Name
Value
Implied Action
RSI (14)
45.23
Neutral
STOCH (9,6)
54.76
Neutral
STOCHRSI (14)
71.21
Neutral
MACD (12,26)
-0.94
Sell
ADX (14)
33.23
Neutral
Williams %R
-28.46
Buy
CCI (14)
27.52
Neutral
ATR (14)
1.29
-
Ultimate Oscillator
47.14
Neutral
ROC
2.30
Buy
Rapport Therapeutics, Inc.’s (RAPP) Relative Strength Index (RSI) is 45.23, creating a Neutral signal.
Rapport Therapeutics, Inc.’s (RAPP) Trend Strength Indicator (ADX) is 33.23, creating a Neutral signal.
Rapport Therapeutics, Inc.’s (RAPP) Commodity Channel Index (CCI) is 27.52, creating a Neutral signal.
Rapport Therapeutics, Inc.’s (RAPP) Price Rate of Change (ROC) is 2.30, creating a Buy signal.

FAQ

Is RAPP a Buy, Hold, or Sell?
Based on RAPP’s technical indicators, RAPP is a Hold.
    What is RAPP’s RSI (14)?
    RAPP’s RSI (14) is 45.23, which suggests RAPP is a Neutral.
      What is RAPP’s MACD?
      RAPP’s MACD is -0.94, which suggests RAPP is a Sell.
        What is RAPP’s 5-day moving average?
        RAPP’s 5-day moving average is 9.95, which suggests RAPP is a Buy.
          What is RAPP’s 20-day moving average?
          RAPP 20-day moving average is 9.78, which suggests RAPP is a Buy.
            What is RAPP’s 50-day moving average?
            RAPP’s 50-day moving average is 12.78, which suggests RAPP is a Sell.
              What is RAPP’s 200-day moving average?
              Currently, no data Available
              What is RAPP’s Williams % R (14)?
              RAPP’s Williams % R (14) is -28.46, which suggests RAPP is a Buy.
                What is RAPP’s CCI (14)?
                RAPP’s CCI (14) is 27.52, which suggests RAPP is a Neutral.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis